Providing COVID-19 Therapeutics and Clinical Guidance in Skilled Nursing Facilities

Residents in skilled nursing facilities (SNFs) are at high risk for hospitalization and death from COVID-19 (1,2). Outpatient COVID-19 therapeutics reduce severe illness, and they became more available locally as of April 25, 2022 (3,4). However, evolving guidance and medication administration logistics created barriers to timely use of therapeutics for SNF residents in a large metropolitan city. October 31, 2022, 8.1% reported COVID-19 cases among area SNF residents (n=1,957) were treated with therapeutics and 20 (25%) of 79 unique facilities reported therapeutics use.